Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 11th:
OMV Aktiengesellschaft OMVKY: This energy and chemicals company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
OMV AG price-consensus-chart | OMV AG Quote
OMV has a price-to-earnings ratio (P/E) of 5.96, compared with 7.30 for the industry. The company possesses a Value Score of A.
OMV AG pe-ratio-ttm | OMV AG Quote
Pacira BioSciences, Inc. PCRX: This non-opioid pain management and regenerative health solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 21% over the last 60 days.
Pacira BioSciences, Inc. price-consensus-chart | Pacira BioSciences, Inc. Quote
Pacira has a price-to-earnings ratio (P/E) of 7.69, compared with 24.45 for the S&P 500. The company possesses a Value Score of A.
Pacira BioSciences, Inc. pe-ratio-ttm | Pacira BioSciences, Inc. Quote
EZCORP, Inc. EZPW: This pawn services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
EZCORP, Inc. price-consensus-chart | EZCORP, Inc. Quote
Ezcorp has a price-to-earnings ratio (P/E) of 10.33, compared with 15.30 for the industry. The company possesses a Value Score of A.
EZCORP, Inc. pe-ratio-ttm | EZCORP, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
EZCORP, Inc. (EZPW) : Free Stock Analysis Report
Pacira BioSciences, Inc. (PCRX) : Free Stock Analysis Report
OMV AG (OMVKY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.